1 unknown. 1 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 1 | Unknown 1 |
Follow Andria Ford: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of Crizanlizumab for Prevention of Silent Cerebral Infarcts in SCA Crizanlizumab - Sickle Cell Disease | Not applicable | Unknown | Andria Ford | 31 | 2022-08-01 | 2023-03-06 |
crizanlizumab (1)
United States (1)